BRM-421

N/A

Report date: 2023/04/20 17:22:00
NME

Base Information

Drug NameBRM-421
Drug Alias NamePDSPBRM-421
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionPigment epithelium-derived factor modulators
TargetsPigment epithelium-derived factor
Therapy Area/IndicationsDry Eye SyndromesXerophthalmiaKeratoconjunctivitis Sicca
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBrim Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBrim Biotechnology IncGrand Pharmaceutical （China） Co Ltd
Inactive CompaniesN/A
Active IndicationsDry Eye SyndromesXerophthalmiaKeratoconjunctivitis Sicca
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A